ROLKE JAMES (Chief Executive Officer) received a stock award from REVELATION BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2025ACC: 0000950170-25-020109
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+30.09K
Net shares
Net buyer
$116.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
30.09K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30.09K
Price / share
$3.87
Trade value
$116.47K
% of position
71654.8%
2/11/2025
42.00→30.14K
Total
Net shares
+30.09K
Net value
$116.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2025 | A · Award | +30.09K | $3.87 | $116.47K | 71654.8% | 42.00 | 30.14K |
| Total | +30.09K | $116.47K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned42.00
Total
42.00 direct42.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 42.00 | Direct |
| Total | 42.00 | 42.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported